Compare Sanurhasta Mitra Tbk. (MINA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanurhasta Mitra Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Sanurhasta Mitra Tbk. trades at Rp274 (market cap 2.7T, 55.12M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Sanurhasta Mitra Tbk. is far larger — about 25.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MINA | SCPI | |
|---|---|---|
Market Cap | 2.7T | 104.4B |
Volume | 55.12M | — |
Lot | 551.16K | — |
Turnover | 14.92B | — |
Average Price | 270.69 | — |
Value | 14.92B | — |
Indicative Equilibrium Price | 274 | — |
Indicative Equilibrium Volume | 6.22K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanurhasta Mitra Tbk.
PT Sanurhasta Mitra (the Company) was established on December 29, 1993 by Notarial Deed No. 196 of Ny. Pudji Redjeki Irawati, S.H., Notary in Jakarta and has been corrected by notarial deed No. 32 dated August 5, 1994 by the Notary substitute Drs. Sutjahjo Srudji, S.H., Notary in Jakarta. PT Sanurhasta Mitra as the shareholder of PT Minna Padi Resorts, also has its own business on The Santai, a very luxurious style villa for your family vacation that has been operated by Lifestyle Retreats Pte. Ltd. Within the resort concept. The Santai surrounded with rice field and the quiet rural ambience.
Read more on MINA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
